2012;307:157 64. S5.1.5.2-49. Leaf A, Kang JX, Xiao YF, et al. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mecha- nism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646 52. S5.1.5.2-50. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885 99. S5.1.5.2-51. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocar- dial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897 903. S5.1.5.2-52. Kromhout D, Giltay EJ, Geleijnse JM. n-3 fatty acids and car- diovascular events after myocardial infarction. N Engl J Med. 2010;363:2015 26. S5.1.5.2-53. Rauch B, Schiele R, Schneider S, et al. OMEGA, a randomized, pla- cebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122:2152 9. S5.1.5.2-54. Burr ML, Ashfield-Watt PA, Dunstan FD, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57:193 200. S5.1.5.2-55. Galan P, Kesse-Guyot E, Czernichow S, et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ. 2010;341:c6273. S5.1.5.2-56. Bosch J, Gerstein HC, Dagenais GR, et al. n-3 fatty acids and car- diovascular outcomes in patients with dysglycemia. N Engl J Med. 2012;367:309 18. S5.1.5.2-57. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA. 1999;282:2340 6. S5.1.5.2-58. Buber J, Goldenberg I, Moss AJ, et al. 